WealthShield Partners’s Gilead Sciences GILD Stock Holding History

WealthShield Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.71M	Sell	13,549 -383	-3%	-$50.5K	0.26%	107
2026 Q1	$1.94M	Sell	13,932 -168	-1%	-$23.5K	0.22%	129
2025 Q4	$1.73M	Buy	+14,100	New	+$1.71M	0.19%	129
2021 Q3	–	Sell	-2,437	Closed	-$168K	–	435
2021 Q2	$168K	Buy	2,437 +739	+44%	+$49.3K	0.03%	286
2021 Q1	$110K	Buy	+1,698	New	+$109K	0.02%	326
2018 Q2	–	Sell	-2,739	Closed	-$206K	–	253
2018 Q1	$206K	Buy	+2,739	New	+$218K	0.13%	116

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WealthShield Partners's GILD Position: Q2 2026 in Review

WealthShield Partners reduced its Gilead Sciences (GILD) stake by 2.7% in Q2 2026, selling an estimated $50.5K and leaving 13,549 shares worth $1.71M. The position accounts for 0.26% of the portfolio, ranked #107.

WealthShield Partners first reported a position in GILD in Q1 2018 and has held it in 6 quarters since. The position peaked at $1.94M in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

WealthShield Partners held 13,549 shares of Gilead Sciences worth $1.71M as of Q2 2026.
WealthShield Partners sold 383 Gilead Sciences shares in Q2 2026, an estimated $50.5K.
Gilead Sciences made up 0.26% of WealthShield Partners's portfolio in Q2 2026, its #107 holding.
WealthShield Partners first reported a position in Gilead Sciences in Q1 2018 and has held it in 6 quarters since.
WealthShield Partners's Gilead Sciences position peaked at $1.94M in Q1 2026.
2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on WealthShield Partners's 13F filing for Q2 2026, filed 12 Aug 2026.